Corrigendum: Prediction of early treatment response to the combination therapy of TACE plus lenvatinib and anti-PD-1 antibody immunotherapy for unresectable hepatocellular carcinoma: Multicenter retrospective study - Li, Shuqun; Wu, Junyi; Wu, Jiayi; Fu, Yangkai; Zeng, Zhenxin; Li, Yinan; Li, Han; Liao, Weijia; Yan, Maolin (Frontiers in Immunology, 2023)